PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17909054-1	2007	The antineoplastic drug sorafenib (BAY 43-9006) is a multikinase inhibitor that targets the serine-threonine kinase B-Raf as well as several tyrosine kinases.	Sorafenib	24-33	B-Raf proto-oncogene, serine/threonine kinase	Homo sapiens	116-121	
17909054-1	2007	The antineoplastic drug sorafenib (BAY 43-9006) is a multikinase inhibitor that targets the serine-threonine kinase B-Raf as well as several tyrosine kinases.	Sorafenib	35-46	B-Raf proto-oncogene, serine/threonine kinase	Homo sapiens	116-121